@sylv_villeneuve @alexa_pichetb So well deserved! She got amazing mentors and is well on her way te being a great one herself. Amazing scientist and human being. Congrats @alexa_pichetb ! 🍾🎊
@relajoie Enjoyed the exact same walk after HAI 2020 in what appears to be a similar (windy?) weather! A great way to relax and unwind after the best conference out there 😉
If you haven’t applied yet, I don’t know what you’re doing! Great opportunity with a young PI who has a track record of doing incredible work and being a nice guy as well. Can’t go wrong here!
‼️Postdoc opportunity‼️ Please RT 🙏
Are you interested in:
* Neurodegenerative disease
* Multi-omic analysis
* Machine learning/AI
* Neuroimaging
Come work with me and the whole BioFINDER team!
Apply here: https://t.co/3gsDuHy8nD
A quick thread about the position 👇
@alexa_pichetb Congrats Alexa! Such important work as the development of these biomarkers continue. And such a valuable cohort of individuals. Great work (as always) ! :)
Couldn’t agree more. The (sometimes) ‘cult-like’ reverence of PhD in academic circles also drives incredibly talented people out of non-faculty uni jobs because they feel they don’t belong. A little humility goes a long way.
Some of the most brilliant, bold & incredibly smart colleagues I work with do not have PhDs. Having a Phd does not automatically mean 1) that you you’re an expert at it all 2) that you have the most innovative ideas or 3) that you should be the loudest voice in the room.
The UCL/GOT biomarkers course with a line up of GOATs in the field! If you’ve never attended, this is 100% worth it. Wish I could be a graduate student just so I could attend again...
This year’s “UCL/UGOT Biomarkers for neurodegenerative diseases” course is probably the best we have ever offered, very much looking forward to meeting all the delegates and speakers in person in London very soon!
@UCLIoN@drcionucl@goteborgsuni@tautangles @aitanasogorb
@DrTFromKC These are still early days for this assay but we have to see how it performs in pops. with a larger proportion of healthy individuals with more tau deposition. For now, it looks like a screening tool for research purposes. Much validation is needed on the road to clinical use!
@DrTFromKC You’re right that this is particularly apparent for associations with tau PET! Two things: 1. Results in the paper are reported using robust regression (i.e. tampering the effect of outliers on beta estimates) 2. This cohort is very early in the disease process (i.e. low tau)
Two years, a transition to industry and a pandemic later, I am delighted to share our investigation of plasma biomarkers in @prevent_ad! A great collab with the world’s best initiated with our friends @_michael_scholl@NicholasAshton and @sylv_villeneuve’s lab @mcgillu !
If you haven’t yet, you should apply. Both Nico and Rik are amazing scientists and great humans. The type of environment you should look for when PhD hunting!
⚡️ Job alert #1: @nfranzme and I are looking for a motivated #PhD student to work on protein progression modelling using human #neuroimaging data. This is a 4-year shared position between @AlzheimerAms (Amsterdam) and @ISDneuroimaging (Munich). Apply here: https://t.co/B4UWNzhBIL
#PsychTwitter, I have a student graduating this year looking for research opportunities in I/O. If anyone has any leads, that would be much appreciated!